Headline News

 

Obsidian Therapeutics Announces Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors

Posted on January 22, 2019

New Novo Holdings Investments by REPAIR Impact Fund

Posted on January 22, 2019

Tentative USFDA Approval for Zydus’ Esomeprazole Magnesium Delayed-Release Capsules USP

Posted on January 22, 2019

Portfolio of Seven Marketed Oncology Injectable Products from Spectrum Pharmaceuticals to be Acquired by Acrotech Biopharma

Posted on January 22, 2019

Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO® Lilly Reports

Posted on January 22, 2019

Succession Plan to Appoint New GSK Chairman Announced

Posted on January 22, 2019

FDA approves Lupin Levothyroxine Sodium Tablets USP

Posted on January 22, 2019

US FDA Approves Wockhardt Leukemia drug

Posted on January 22, 2019

Sartorius Stedim Biotech Introduces BIOSTAT® RM TX with Flexsafe® RM TX for Producing Consistent Quality Cellular Products

Posted on January 21, 2019

ASLAN Pharmaceuticals to Present Positive Varlitinib Data in First-Line Biliary Tract Cancer in Combination With Chemotherapy at ASCO GI

Posted on January 15, 2019

Sanofi Announce New England Journal of Medicine Published Positive Results of the Pivotal Trial of Cablivi® (caplacizumab) for Rare Blood Clotting Disorder

Posted on January 15, 2019

Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO

Posted on January 15, 2019

Hetero Launches Generic Lapatinib Under The Brand Name ‘Hertab’ In India

Posted on January 15, 2019

Lupin Receives European Commission Approval for Orphan Drug NaMuscla® for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Posted on January 15, 2019

Final USFDA Approvals Received by Zydus for Betamethasone Dipropionate Cream and Amlodipine & Atorvastatin Tablets

Posted on January 15, 2019